Langhorne, PA, United States of America

George F Bulbenko


Average Co-Inventor Count = 1.6

ph-index = 3

Forward Citations = 32(Granted Patents)


Company Filing History:


Years Active: 1977-1985

Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovations of George F. Bulbenko: A Pioneer in Biochemical Assays and Blood Separation

Introduction

George F. Bulbenko, located in Langhorne, PA, is an accomplished inventor known for his significant contributions to biochemical assays and blood component separation. With a total of three patents to his name, Bulbenko has made noteworthy advancements that enhance both the efficiency and accuracy of laboratory processes.

Latest Patents

Bulbenko's most recent patents demonstrate his innovative approach towards medical and biochemical technologies. One of his inventions, titled “.beta.-Amylase determination,” features a reagent suitable for .alpha.-amylase determinations. This novel reagent contains a modified, blocked amylaceous polysaccharide substrate such as starch glycolate, alongside an exating agent by amylose, a buffer, and an enzymatic glucose measuring system. The glycolate substrate is specifically chosen to maintain a methylated glucose to glucose ratio between 1:4 and 1:16. This unique system allows for an expedited assay that can be completed in a single vial within seven minutes, with capabilities for automation.

Another significant invention of Bulbenko is a blood separation apparatus that includes a chromatographic column designed for the separation of blood components. This invention employs an adsorbent along with a lysing agent for hemolyzing blood, enabling whole blood samples to be applied directly to the column for effective hemolysis and blood separation in one operational step. This invention is particularly significant for the analysis of fast-running hemoglobin, specifically glycosylated hemoglobin.

Career Highlights

Bulbenko's career includes pivotal roles at prominent companies in the medical field. He has worked with Becton Dickinson and Company Limited, a leading provider of medical supplies and devices, as well as at Electro-Nucleonics, Inc., where advanced solutions in nucleonics were developed. His work in these companies solidified his foundation in the intersection of technology and healthcare.

Collaborations

Throughout his career, Bulbenko has had the opportunity to collaborate with distinguished colleagues, including J. Eliot Woodbridge and J. John Marshall. These collaborations have not only enhanced his innovative capabilities but have also led to the development of products that meet pressing medical needs.

Conclusion

George F. Bulbenko's contributions to the fields of biochemical assays and blood separation have marked him as a valuable inventor in the medical community. His patents reflect a deep commitment to innovation, driving forward the capabilities of medical testing and analysis. As technology evolves, Bulbenko's inventions will likely continue to play a crucial role in improving healthcare outcomes and laboratory efficiencies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…